ADAMTS13 activity in sickle cell disease
- 1 July 2006
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 81 (7), 492-498
- https://doi.org/10.1002/ajh.20653
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Sickle-cell diseaseThe Lancet, 2004
- Recent Advances in Thrombotic Thrombocytopenic PurpuraHematology, 2004
- Von Willebrand factorCurrent Opinion in Hematology, 2003
- Sickle cell vaso-occlusion: multistep and multicellular paradigmCurrent Opinion in Hematology, 2002
- Pulmonary Thrombotic Arteriopathy in Patients With Sickle Cell DiseaseArchives of Pathology & Laboratory Medicine, 2001
- Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell–endothelium interactions induced by platelet-activating factorBlood, 2000
- Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusionBlood, 1993
- Unusually large von willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cellsAmerican Journal of Hematology, 1993
- Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow.JCI Insight, 1987
- Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation.Stroke, 1978